SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-14-039047
Filing Date
2014-12-16
Accepted
2014-12-16 19:19:09
Documents
1
Period of Report
2014-12-15

Document Format Files

Seq Description Document Type Size
1 MALLEY F4 rrd420392.html 4  
1 MALLEY F4 rrd420392.xml 4 3964
  Complete submission text file 0001181431-14-039047.txt   5414
Mailing Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024
Business Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024 (424) 248-6500
PUMA BIOTECHNOLOGY, INC. (Issuer) CIK: 0001401667 (see all company filings)

IRS No.: 770683487 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 295 CLAYTON DENVER CO 80206
Business Address
Malley Thomas (Reporting) CIK: 0001403322 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35703 | Film No.: 141290859